# Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

> **NCT03298334** · PHASE1,PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 600 (estimated)

## Conditions studied

- Cesarean Delivery Affecting Newborn
- Obesity, Childhood
- Intestinal Microbiome
- Microbiota
- Host Microbial Interactions
- Gastrointestinal Microbiome

## Interventions

- **BIOLOGICAL:** Vaginal Seeding
- **OTHER:** No Vaginal Seeding

## Key facts

- **NCT ID:** NCT03298334
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-01
- **Primary completion:** 2027-04
- **Final completion:** 2029-04
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03298334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03298334, "Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03298334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*